1. Home
  2. GYGY vs EVAX Comparison

GYGY vs EVAX Comparison

Compare GYGY & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GYGY

Game Your Game Inc. Common Stock

N/A

Current Price

$0.45

Market Cap

25.5M

Sector

Technology

ML Signal

N/A

Logo Evaxion Biotech

EVAX

Evaxion Biotech

SELL

Current Price

$3.00

Market Cap

27.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GYGY
EVAX
Founded
2
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
27.5M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
GYGY
EVAX
Price
$0.45
$3.00
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.25
AVG Volume (30 Days)
★ 3.4M
35.7K
Earning Date
11-20-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$2.77
52 Week High
$11.81
$12.15

Technical Indicators

Market Signals
Indicator
GYGY
EVAX
Relative Strength Index (RSI) 15.04 39.88
Support Level N/A $2.92
Resistance Level $1.27 $3.62
Average True Range (ATR) 0.09 0.13
MACD 0.08 -0.03
Stochastic Oscillator 1.25 0.00

Price Performance

Historical Comparison
GYGY
EVAX

About GYGY Game Your Game Inc. Common Stock

Game Your Game Inc develops and markets AI-based sports performance tracking technology that is prominently focused on the golf industry. Its products include GPS shot tracking hardware, AI algorithms, and a smart coaching app to provide players with real-time insights, recommendations, and personalized performance analytics. The company's technology consists of the GameGolf KZN AI platform, which is an integrated golf performance ecosystem of proprietary shot-tracking hardware and subscription-based software solutions. It generates revenue from the sale of KZN AI hardware device and from recurring annual subscription fees for continued access to the GameGolf App, GameGolf Smart Caddie and the GameGolf platform. Geographically, the company operates mainly in the United States and Europe.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: